{"id":31258,"date":"2018-10-10T16:42:56","date_gmt":"2018-10-10T16:42:56","guid":{"rendered":"https:\/\/www.upjs.sk\/lekarska-fakulta\/klinika\/root\/iv-interna\/vyskum\/publikacie\/"},"modified":"2022-11-13T22:07:20","modified_gmt":"2022-11-13T21:07:20","slug":"publikacie","status":"publish","type":"cpt_klinika","link":"https:\/\/www.upjs.sk\/lekarska-fakulta\/klinika\/iv-interna\/vyskum\/publikacie\/","title":{"rendered":"Publik\u00e1cie v \u010dasopisoch kateg\u00f3rie A od roku 2008"},"content":{"rendered":"
2018<\/strong><\/span><\/strong><\/p>\n Demkov\u00e1 K, Koz\u00e1rov\u00e1 M, Malachovsk\u00e1 M, Javorsk\u00fd M, Tk\u00e1\u010d I.<\/strong> Osteoprotegerin concentration is associated with the presence and severity of peripheral arterial disease in type 2 diabetes mellitus. Vasa 2018;47:131-135. IF 2017 1,210<\/strong><\/p>\n Koz\u00e1rov\u00e1 M, Malachovsk\u00e1 Z<\/span><\/strong>, \u017didzik J, Javorsk\u00fd M, Demkov\u00e1 K<\/strong>, Habalov\u00e1 V, Tk\u00e1\u010d I<\/strong>. Risk allele of gene variant rs6584389 is associated with increased intima-media thickness in patients with type 2 diabetes. Vasa 2018;47:279-284. IF 2017 1,210<\/strong><\/span><\/p>\n 2017<\/strong><\/span><\/strong><\/p>\n Gotthardov\u00e1 I, Javorsk\u00fd M<\/span><\/strong>, Klim\u010d\u00e1kov\u00e1 L, Kvapil M, Schroner Z, Koz\u00e1rov\u00e1 M, Malachovsk\u00e1 M, \u00dcrgeov\u00e1 A<\/strong>, \u017didzik J, Tk\u00e1\u010d I<\/strong>. KCNQ1<\/em> gene polymorphism is associated with glycaemic response to treatment with DPP-4 inhibitors. Diabetes Res Clin Pract 2017;130:142-147. IF 2017 2.548<\/strong><\/span><\/p>\n 2016<\/strong><\/span><\/strong><\/p>\n Javorsk\u00fd M, Gotthardov\u00e1 I<\/span><\/strong>, Klim\u010d\u00e1kov\u00e1 L, Kvapil M, \u017didzik J, Schroner Z, Doubravov\u00e1 P, Ga\u013ea I, Draveck\u00e1 I, Tk\u00e1\u010d I<\/strong>. A missense variant in GLP1R gene is associated with the glycaemic response to treatment with gliptins. Diabetes, Obesity and Metabolism. – ISSN 1463-1326. – Vol. 18, no. 9 (2016), s. 941-944. IF 6,198<\/strong><\/p>\n Tk\u00e1\u010d I, Gotthardov\u00e1 I.<\/strong> Pharmacogenetic aspects of the treatment of Type 2 diabetes with the incretin effect enhancers. Pharmacogenomics. – ISSN 1462-2416. – Vol. 17, no. 7 (2016), s. 795-804. IF 2,710<\/strong><\/p>\n Zaharenko L, Kalnina I, Geldnere K, Konrade I, Solveiga G, \u017didzik J, Javorsk\u00fd M,<\/strong> Lejnieks A, Nikitina-Zake L, Fridmanis D, Peculis R, Radovica-Spalvina I, Hartmane D, Pugovics O, Tk\u00e1\u010d I,<\/strong> Klim\u010d\u00e1kov\u00e1 L, Pigags V, Klovins J. Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients . European Journal of Endocrinology. – ISSN 0804-4643. – Vol. 175, no. 6 (2016), s. 531 – 540. IF 3,892<\/strong><\/p>\n Zhou K, Soong Y, \u2026Tk\u00e1\u010d I, Javorsk\u00fd M,<\/strong> \u017didzik J\u2026, Giacomini K, Pearson ER. Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin. Nature Genetics. – ISSN 1061-4036. – Vol. 48, no. 9 (2016), s. 1055 – 1061. IF 31,616<\/strong><\/p>\n Tk\u00e1\u010d I,<\/strong> Raz I. Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes. Diabetes Care. – ISSN 0149-5992. – Vol. 40, no. 2 (2017), s. 284 – 286. IF 8,934<\/strong><\/span><\/p>\n 2015<\/strong><\/span><\/strong><\/p>\n Tk\u00e1\u010d I, Javorsk\u00fd M<\/strong>, Klim\u010d\u00e1kov\u00e1 L, \u017didzik J, Ga\u013ea I, Babjakov\u00e1 E, Schroner Z, \u0160tolfov\u00e1 M, Hermanov\u00e1 H, Habalov\u00e1 V. A\u00a0pharmacogenetic association between a\u00a0variation in calpain 10 (CAPN10<\/em>) gene a\u00a0the response to metformin treatment in patients with type 2 diabetes. Eur J Clin Pharmacol 2015;71(1):59-63. IF 2.966<\/strong><\/p>\n Tk\u00e1\u010d I. <\/strong>Genetics of drug response in type 2 diabetes. Curr Diab Rep 2015;15:617. IF 3.080<\/strong><\/p>\n 2014<\/span><\/strong><\/strong><\/p>\n Tisko R, Sopkova Z, Habalova V, Dorkova Z, Slaba E, Javorsky M<\/strong>, Tkac I<\/strong>, Riha RL, Tkacova R. Effects of APOE genotype on serum lipids in obstructive sleep apnoea. Eur Respir J 2014;43(4):1097-1105. IF 2014 7.636<\/strong><\/p>\n 2013<\/strong><\/span><\/strong><\/p>\n Becker ML, Pearson ER, Tk\u00e1\u010d I. <\/strong>Pharmacogenetics of oral antidiabetic drugs. Int J Endocrionol 2013;2013, Art. 686315: 10 pp. IF 2.518<\/strong><\/p>\n Tk\u00e1\u010d I.<\/strong> Cardiovascular Importance of Hyperglycemia and Hypoglycemia. Diabetes Care 2013;36(Suppl 2):S267-S271. IF 7.735<\/strong><\/p>\n Tk\u00e1\u010d I<\/strong>, Klim\u010d\u00e1kov\u00e1 L, Javorsk\u00fd M, Fabianova M, Schroner Z,<\/strong> Hermanov\u00e1 H,\u00a0 Babjakov\u00e1 E,<\/strong> Tk\u00e1\u010dov\u00e1 R. Pharmacogenomic association between a variant in SLC47A1 <\/em>gene and therapeutic response to metformin in type 2 diabetes. Diabetes Obes Metab 2013;15(2):189-191. IF 5.181<\/strong><\/p>\n Javorsk\u00fd M, Babjakov\u00e1 E,<\/strong> Klim\u010d\u00e1kov\u00e1 L, Schroner Z,<\/strong> \u017didzik J, \u0160tolfov\u00e1 M,<\/strong> \u0160alagovi\u010d J, Tk\u00e1\u010d I. <\/strong>Association study between TCF7L2 <\/em>genotype and glycemic control in diabetic patients treated with gliclazide. Int J Endocrinol 2013;2013, Art. 374858: 5 pp. IF 2.518<\/strong><\/p>\n Tkacova R, Ukropec J, Skyba P, Ukropcova B, Pobeha P, Kurdiova T, Joppa P, Klimes I, Tkac I<\/strong>, Gasperikova D. Effects of Hypoxia on Adipose Tissue Expression of NF\u03baB, I\u03baB\u03b1, IKK\u03b3 and IKAP in Patients with Chronic Obstructive Pulmonary Disease. Cell Biochem Biophys 2013;66(1):7-12. IF 1.912<\/strong><\/p>\n Szaboova E<\/strong>, Holoubek D, Tomori Z, Szabo P, Donic V, Stancak B. Severity of nocturnal cardiac arrhythmias correlates with intensity of sleep apnea in men. Adv Exp Med Biol. 2013;755:155-168. IF 1.825<\/strong><\/p>\n 2012<\/strong><\/span><\/strong><\/p>\n Javorsky M,<\/strong> Klimcakova L, Schroner Z<\/strong>, Zidzik J, Babjakova E, Fabianova M, Kozarova M,<\/strong> Tkacova R, Salagovic J, Tkac I.<\/strong> KCNJ11 <\/em>gene E23K variant and therapeutic response to sulfonylureas. Eur J Intern Med 2012;23(3):245-249. IF 2.000<\/strong><\/p>\n Schroner Z, <\/strong>Javorsk\u00fd M, <\/strong>Halu\u0161kov\u00e1 J, Klim\u010d\u00e1kov\u00e1 L, Babjakov\u00e1 E, Fabianov\u00e1 M,<\/strong> Slab\u00e1 E, Koz\u00e1rov\u00e1 M,<\/strong> Tk\u00e1\u010d I.<\/strong> Variation in CDKAL1 <\/em>gene is associated with therapeutic response to sulphonylureas. Physiol Res 2012;61(2):177-183. IF 1.555<\/strong><\/p>\n Tk\u00e1\u010d I. <\/strong>Highlights from the latest articles in pharmacogenomics of oral antidiabetic drugs. Pharmacogenomics 2012;13(12):1329-1332. IF 3.974<\/strong><\/p>\n Br\u00fasik M, Ukropec J, Joppa P, Ukropcov\u00e1 B, Skyba P, Bal\u00e1\u017e M, Pobeha P, Kurdiov\u00e1 T, Klime\u0161 I, Tk\u00e1\u010d I<\/strong>, Ga\u0161per\u00edkov\u00e1 D, Tk\u00e1\u010dov\u00e1 R. Circulatory and adipose tissue leptin and adiponectin in relationship to resting energy expenditure in patients with chronic obstructive pulmonary disease. Physiol Res 2012;61(5):469-480; IF 1.555<\/strong><\/p>\n Lukan N<\/strong>, Racz O, Paulovicova E, Mocnejova I, Petrovicova J. Determination of immunological stress and oxygen free radical formation in white blood cells during allergen immunotherapy. Med Sci Monit. 2012;18(7):PR13-7. IF 1.699<\/strong><\/p>\n 2011<\/strong><\/span><\/strong><\/p>\n Schroner Z, Javorsky M,<\/strong> Tkacova R, Klimcakova L, Dobrikova M,<\/strong> Habalova V,\u00a0 Kozarova M,<\/strong> Zidzik J, Rudikova M, Tkac I<\/strong>. Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes. Diabetes Obes Metab 2011;13(1):89-91. IF 3.379<\/strong><\/p>\n Tkacova R, Ukropec J, Skyba P, Ukropcova B, Pobeha P, Kurdiova T, Joppa P, Klimes I, Tkac I<\/strong>,\u00a0 Gasperikova D. Increased adipose tissue expression of proinflammatory CD40, MKK4 and JNK in patients with very severe chronic obstructive pulmonary disease. Respiration 2011;81:386-393. IF 2.258<\/strong><\/p>\n Pobeha P, Ukropec, Skyba P, Ukropcova B, Joppa P, Kurdiova T, Javorsky M<\/strong>, Klimes I, Tkac I<\/strong>, Gasperikova D, Tkacova R. Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. Bone 2011;48(5):1008-1014. IF 4.023<\/strong><\/p>\n Schroner Z, Dobrikova M,<\/strong>\u00a0\u00a0Klimcakova\u00a0\u00a0L, Javorsky M,<\/strong>\u00a0\u00a0Zidzik J,\u00a0\u00a0Kozarova\u00a0\u00a0M<\/strong>, Hudakova\u00a0\u00a0T, Tkacova\u00a0R,\u00a0Salagovic J,\u00a0\u00a0Tkac I. <\/strong>Variation in KCNQ1<\/em> is associated with therapeutic response to sulphonylureas. Med Sci Monit 2011;17(7):CR392-396. IF 1.699<\/strong><\/p>\n 2010<\/strong><\/span><\/strong><\/p>\n Skyba P, Ukropec J, Pobeha P, Ukropcova B, Joppa P, Kurdiova T, Stroffekova K, Brusik M, Klimes I, Tkac I, <\/strong>Gasperikova D, Tkacova R. Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease. Mediators Inflamm 2010; Article ID 173498, 9 pages. IF 3.263<\/strong><\/p>\n Szaboova E<\/strong>, Tomori Z, Szabo P, Gresova S, Donic V. Severe nocturnal cardiac arrhythmias caused by sleep apnea-induced hypoxemia in males.\u00a0 Eur J Med Res. 2010;15(Suppl 2):193-1977. IF 0.978<\/strong><\/p>\n 2009<\/strong><\/span><\/strong><\/p>\n Hab\u00e1lov\u00e1 V, Klim\u010d\u00e1kov\u00e1 L, \u017didzik J, Tk\u00e1\u010d I. <\/strong>Rapid and cost effective genotyping method for polymorphisms in PPARG, PPARGC1 and TCF7L2 genes. Mol Cell Probe 2009;23:52-54. IF 2.078<\/strong><\/p>\n Tk\u00e1\u010d I<\/strong>, Mili\u010devi\u0107 Z, Jermendy G. How to interprete the results of the HEART2D trial? Diabetes Res Clin Pract. 2009;86(Suppl 1):S53-S56. IF 2.754<\/strong><\/p>\n Tk\u00e1\u010d I. <\/strong>Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials. Diabetes Res Clin Pract. 2009;86(Suppl 1):S57-S62. IF 2.754<\/strong><\/p>\n 2008<\/strong><\/span><\/strong><\/p>\n Tk\u00e1\u010dov\u00e1 R, Dorkov\u00e1 Z, Mol\u010d\u00e1nyiov\u00e1 A, Rad\u00edkov\u00e1 \u017d, Klime\u0161 I, Tk\u00e1\u010d I. <\/strong>Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea. Med Sci Monit 2008;14(9):CR438-444. IF 1.699<\/strong><\/p>\n Luk\u00e1n N<\/strong>, R\u00e1cz O, Mocnejov\u00e1 I, Tk\u00e1\u010d I. <\/strong>Monitoring antioxidant enzymes in red cells during allergen immunotherapy. J Physiol Biochem 2008;64(2):143-148. IF 1.357<\/strong><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":31253,"menu_order":3,"template":"","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[],"tags":[],"tax_aktuality":[],"class_list":["post-31258","cpt_klinika","type-cpt_klinika","status-publish","hentry"],"acf":{"acf_link_na_externy_obsah":""},"yoast_head":"\n